About Accuray, Inc. 
Accuray, Inc.
Pharmaceuticals & Biotechnology
Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.
Company Coordinates 
Company Details
1310 Chesapeake Ter , SUNNYVALE CA : 94089-1100
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 45 Schemes (20.73%)
Foreign Institutions
Held by 37 Foreign Institutions (4.62%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Louis Lavigne
Independent Chairperson of the Board
Mr. Joshua Levine
President, Chief Executive Officer, Director
Ms. Elizabeth Davila
Independent Director
Mr. James Hindman
Independent Director
Ms. Beverly Huss
Independent Director
Ms. Anne Le Grand
Independent Director
Mr. Richard Pettingill
Independent Director
Revenue and Profits:
Net Sales:
128 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
Pharmaceuticals & Biotechnology
USD 175 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
1.06
-2.63%
2.15






